4-(6-Amino-purin-9-yl)-cyclopentane-1,2,3-triol

ID: ALA405082

PubChem CID: 469184

Max Phase: Preclinical

Molecular Formula: C10H13N5O3

Molecular Weight: 251.25

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Nc1ncnc2c1ncn2[C@@H]1C[C@@H](O)[C@@H](O)[C@H]1O

Standard InChI:  InChI=1S/C10H13N5O3/c11-9-6-10(13-2-12-9)15(3-14-6)4-1-5(16)8(18)7(4)17/h2-5,7-8,16-18H,1H2,(H2,11,12,13)/t4-,5-,7+,8-/m1/s1

Standard InChI Key:  VFKHECGAEJNAMV-HXOWADHMSA-N

Molfile:  

     RDKit          2D

 18 20  0  0  1  0  0  0  0  0999 V2000
   -3.2412  -20.1613    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5724  -19.6781    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8252  -18.8928    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6503  -18.8905    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9073  -19.6745    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2435  -20.9863    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7885  -19.9353    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4980  -18.1373    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4798  -16.8053    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9727  -17.4646    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7003  -17.0705    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7142  -17.8922    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0107  -18.3134    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2928  -17.9140    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2827  -17.0890    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9869  -16.6717    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9764  -15.8466    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6926  -19.9273    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  3  4  1  0
  4  5  1  0
 11  9  1  0
  9 10  2  0
 10  8  1  0
  5  1  1  0
  1  2  1  0
 11 12  2  0
  1  6  1  6
 12 13  1  0
 13 14  2  0
  2  7  1  6
 14 15  1  0
  2  3  1  0
 15 16  2  0
 16 11  1  0
  3  8  1  1
 16 17  1  0
  8 12  1  0
  5 18  1  6
M  END

Associated Targets(Human)

E6SM (1586 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HeLa (62764 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MT4 (17854 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HEL (6614 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AHCY Tchem Adenosylhomocysteinase (906 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Respiratory syncytial virus (3434 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Vero (26788 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDCK (10148 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 251.25Molecular Weight (Monoisotopic): 251.1018AlogP: -1.56#Rotatable Bonds: 1
Polar Surface Area: 130.31Molecular Species: NEUTRALHBA: 8HBD: 4
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 5#RO5 Violations (Lipinski):
CX Acidic pKa: 12.95CX Basic pKa: 3.69CX LogP: -2.25CX LogD: -2.25
Aromatic Rings: 2Heavy Atoms: 18QED Weighted: 0.48Np Likeness Score: 0.93

References

1. Siddiqi SM, Chen X, Schneller SW, Ikeda S, Snoeck R, Andrei G, Balzarini J, De Clercq E..  (1994)  An epimer of 5'-noraristeromycin and its antiviral properties.,  37  (9): [PMID:8176716] [10.1021/jm00035a020]
2. Ando T, Kojima K, Chahota P, Kozaki A, Milind ND, Kitade Y..  (2008)  Synthesis of 4'-modified noraristeromycins to clarify the effect of the 4'-hydroxyl groups for inhibitory activity against S-adenosyl-L-homocysteine hydrolase.,  18  (8): [PMID:18374570] [10.1016/j.bmcl.2008.03.029]

Source